Based on regulatory findings, such advertising and marketing claims didn’t align with prescribed labeling norms governing toddler diet. The probe additionally flagged broader formulation parameters throughout choose batches, together with non-permitted ranges of biotin that breached statutory commonplace limits, together with discrepancies in dietary breakdown declarations.
The discover additionally referred to Part 3 of the Toddler Milk Substitutes, Feeding Bottles and Toddler Meals (Regulation of Manufacturing, Provide and Distribution) Act, 1992, which locations restrictions on the commercial and promotion of such merchandise.
What FSSAI discovered
The apex meals security regulator initiated an in depth examination of the corporate’s widespread child method strains — particularly NAN Excella Professional Stage 1 and Lactogen Professional 1 — alongside their promotional supplies listed on e-commerce platforms. The scrutiny revealed promotional claims on NAN Excella Professional Stage 1 highlighting “5 HMOs” and “Whey Protein,” whereas promotional textual content for Lactogen Professional 1 asserted that its “Whey Protein” was simple to digest.
Following preliminary clarifications from the FMCG main, the authority decided that each choices breached Regulation 4(2) of the FSS (Meals for Toddler Vitamin) Rules, 2020, which restricts promotional materials designed to spice up the saleability of toddler meals.
Moreover, the advertising and marketing techniques have been discovered to violate Part 3 of the Toddler Milk Substitutes, Feeding Bottles and Toddler Meals (IMS) Act, 1992, which enforces a strict prohibition on promoting and selling such merchandise. The regulatory dragnet expanded additional when laboratory testing of a pattern of Nestlé India’s Observe-up Method revealed sub-standard Biotin content material. A subsequent re-analysis carried out by a Referral Laboratory confirmed that the pattern failed to evolve to prescribed Biotin requirements mandated beneath the 2020 Toddler Vitamin Rules.
In response to the sequence of contraventions, the regulator has formally launched three separate adjudication circumstances towards Nestlé India Restricted masking all three flagged merchandise.
Shares of Nestle India dropped almost 2% throughout buying and selling as buyers factored in potential model erosion, authorized liabilities, and heightened regulatory scrutiny throughout the agency’s core diet vertical.
